Search by Drug Name or NDC

NDC 63323-0374-20 Ondansetron 2 mg/mL Details

Ondansetron 2 mg/mL

Ondansetron is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ONDANSETRON HYDROCHLORIDE.

MedlinePlus Drug Summary

Ondansetron injection is used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Related Packages: 63323-0374-20
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ondansetron Injection

Product Information

NDC	63323-0374
Product ID	63323-374_83824969-e116-40d6-8940-ff134a4f16c0
Associated GPIs	50250065052030
GCN Sequence Number	015869
GCN Sequence Number Description	ondansetron HCl VIAL 2 MG/ML INTRAVEN
HIC3	H6J
HIC3 Description	ANTIEMETIC/ANTIVERTIGO AGENTS
GCN	20011
HICL Sequence Number	006055
HICL Sequence Number Description	ONDANSETRON HCL
Brand/Generic	Generic
Proprietary Name	Ondansetron
Proprietary Name Suffix	n/a
Non-Proprietary Name	ONDANSETRON HYDROCHLORIDE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION
Route	INTRAMUSCULAR; INTRAVENOUS
Active Ingredient Strength	2
Active Ingredient Units	mg/mL
Substance Name	ONDANSETRON HYDROCHLORIDE
Labeler Name	Fresenius Kabi USA, LLC
Pharmaceutical Class	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA076974
Listing Certified Through	2024-12-31

Package

NDC 63323-0374-20 (63323037420)

Pricing Information	N/A
NDC Package Code	63323-374-20
Billing NDC	63323037420
Package	1 VIAL in 1 BOX (63323-374-20) / 20 mL in 1 VIAL
Marketing Start Date	2009-11-18
NDC Exclude Flag	N